In our pan-cancer analysis of 6 immune subtypes, we observed that the C2 subtype, characterized by the dominance of IFN-γ, was distinctly lower in high-TFF3-expression groups than in low-TFF3 groups. The gene discussed is TFF3; the disease is cancer.